Specialty pharmaceutical company Warner Chilcott plc (WCRX) Friday said the United States Food and Drug Administration or FDA has approved a 200 mg strength of tetracycline-class oral antibiotic DORYX Delayed-Release Tablets.
The company said it anticipates the commercially launch of DORYX Delayed-Release 200 mg Tablets in July.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.